Skip to main content

Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Headache

NDC 58602-832 · Aurohealth LLC

Generic nameNaproxen Sodium and Pseudoephedrine Hydrochloride
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE
Strength220; 120 mg/1; mg/1
Pharmacologic classAdrenergic alpha-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], alpha-Adrenergic Agonist [EPC]
Marketing categoryANDA

Packages

58602-832-67 — 2 BLISTER PACK in 1 CARTON (58602-832-67) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

58602-832-83 — 1 BLISTER PACK in 1 CARTON (58602-832-83) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

58602-735 — Naproxen Sodium, 58602-736 — Naproxen Sodium, 58602-737 — Naproxen Sodium, 58602-738 — Naproxen Sodium, 58602-739 — Naproxen Sodium, 58602-803 — Ibuprofen and Pseudoephedrine HCl, 58602-804 — Pseudoephedrine HCl, 58602-807 — Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride, 58602-816 — Naproxen Sodium and Pseudoephedrine Hydrochloride, 58602-819 — Naproxen Sodium, 58602-833 — Guaifenesin and Pseudoephedrine HCl, 58602-834 — Guaifenesin and Pseudoephedrine HCl, 58602-839 — Ibuprofen and Pseudoephedrine Hydrochloride, 58602-844 — Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride, 58602-845 — Naproxen Sodium, 58602-884 — pseudoephedrine hydrochloride, 58809-999 — Chlophedianol Hydrochloride, Dexchlorpheniramine Maleate, and Pseudoephedrine Hydrochloride, 59428-604 — Naproxen Sodium, 59428-748 — Naproxen Sodium, 59428-784 — Naproxen Sodium, +606 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels